SlideShare ist ein Scribd-Unternehmen logo
1 von 24
Recommended pre-requisite presentation for
“The Other Dementias: Virtual Training and Active Learning on Non-Alzheimer’s
Dementias”
three-part series, which is made possible through a grant funded from
TYPICAL CHANGES
• Making a bad decision once in a while
• Missing an occasional monthly payment
• Forgetting which day it is and remembering
later
• Sometimes forgetting which word to use
• Losing things from time to time

A-TYPICAL CHANGES
• Consistent poor judgment and decision
making
• Loss of an ability to manage money
• Inability to keep track of the date or the
season
• Difficulty having a conversation
• Misplacing things and loss of the ability to
retrace steps to find them
There are many
causes of dementia
symptoms.

Is NOT a specific disease.

Alzheimer's disease is
the most common cause
of a progressive
dementia.

Is a GROUP OF SYMPTOMS
affecting intellectual and social abilities
severely enough to interfere with daily
functioning.

Memory loss generally occurs in
dementia, but memory loss alone does
not imply you have dementia.
memory
language

Dementia
causes
changes
in:

thought
navigation
behavior

personality/
mood
• Depression/delirium
• Medication sideeffects
• Excess alcohol use
• Thyroid problems
• Poor diet
• Vitamin deficiencies
• Certain infections

Reversible

DEMENTIAS

•
•
•
•

Alzheimer’s disease
Parkinson’s
Lewy-body dementia
Etc.

Irreversible
2013 Alzheimer’s Disease Facts and Figures, Alzheimer’s
Association
Alzheimer’s
disease is more
prevalent among
African-Americans
than among whites

Estimates range
from 14% to
almost 100%
higher;

There is a greater
familial risk of
Alzheimer’s in
African-Americans

The cumulative
risk of dementia
among firstdegree relatives
of AfricanAmericans who
have Alzheimer’s
disease is 43.7%

Genetic and environmental factors may work differently
to cause Alzheimer’s disease in African-Americans
Data from a large-scale longitudinal study indicate that persons
with a history of either high blood pressure or high cholesterol
levels are twice as likely to get Alzheimer’s disease. Those with
both risk factors are four times as likely to become demented.

65% of African-American Medicare beneficiaries have
hypertension, compared to 51% of white beneficiaries.

They are also at higher risk of stroke.
(Data from the Current Medicare Beneficiary Survey)

African-Americans have a 60% higher risk of type 2 diabetes —
a condition that contributes directly to vascular disease.

African-Americans have a higher rate of vascular dementia than
white Americans.

http://www.alz.org/national/documents/report_africanamericanssilentepidem
Brain
disorder,
most
common
form of
dementia
Affects
5% of
people at
age 65

Affects
50% of
people
age 85+

ASSOCIATED RISK FACTORS:
•
•
•
•
•
•
•
•
•
•

TREATMENT:
•
•

Late-onset
(65+) is
most
common, s
lowestprogressin
g

Average
course of
DAT: 6-20
years

Age
Family history
Down syndrome
Incidence higher in women
Alcohol use
Atherosclerosis
Blood pressure
Cholesterol
Depression
Diabetes (type 2)

•
•

No treatment available to slow or stop the deterioration of
brain cells in Alzheimer's disease.
US FDA has approved five drugs that temporarily slow
worsening of symptoms for about 6 - 12 months.
Effective for only about ½ of the individuals who take them.
Inconclusive research:
Vitamin E
Anti-inflammatory drugs
Estrogen
Vaccine
Diet

INCIDENCE: AD more prevalent among African-Americans
and Hispanics
Plaques

Acethylcholine Deficiency

Tangles
Memory loss that
disrupts daily
functioning
Challenges in
planning or solving
problems

Changes in mood and
personality

Withdrawal from work
or social activities

Difficulty completing
familiar tasks at
home, at work or at
leisure

Decreased or poor
judgment

Confusion with time
or place

Trouble
understanding visual
images and spatial
relationships

Misplacing things and
losing the ability to
retrace steps
New problems with
words in speaking or
writing
VaD can be
cortical and
subcortical

2nd most
common
dementia
after
Alzheimer's
disease
Result of a
damage to
the brain
caused by
problems
with the
arteries
serving the
brain or
heart.
Approx. 2530% of all
dementias
are VaD

Prevalence
of VaD
ranges
from 1 to 4
percent in
people over
the age of
65.

CAUSES:
• Untreated high blood pressure
• Diabetes
• High cholesterol
• Heart disease
ASSOCIATED SYMPTOMS:
• Confusion and agitation; depression
• Unsteady gait
• Problems with memory
• Urinary
frequency, urgency, incontinence
• Night wandering
• Decline in ability to organize
thoughts/actions, difficulty planning
• Poor attention/concentration
TREATMENT:
Damage caused by infarcts cannot be
reversed. Future cerebrovascular
incidents can be controlled (control of
cardiovascular risk factors)
Pick's disease
affects parts of the
brain that contain
fibrous tangles
made up of an
abnormal protein
called tau protein

Group of
diseases
characterized
by the
degeneration
of nerve cells
in the F-T
areas of the
brain

Begins earlier
and
progresses
faster than
AD

Occurs at
ages younger
than AD, i.e.,
40-70.

One form of
this condition
is Pick's
disease.

(Fronto-temporal
areas of the brain are
generally associated
with
personality, behavior
and language). In
these
dementias, portions
of these lobes
atrophy.

CAUSES:
• Unknown
• Possible genetic mutations.
ASSOCIATED SYMPTOMS:
• socially inappropriate behaviors
• loss of mental flexibility
• decline in personal hygiene
• language problems, and
• movement disorders
• difficulty with concentration and
thinking.
CJD is a
degenerative
brain
disorder that
leads to
dementia
and,
ultimately,
death. (rapid
progression)
Variant CJD is
linked primarily to
eating beef
infected with
bovine
spongiform
encephalopathy
(mad cow
disease.

The "classic"
CreutzfeldtJakob
disease has
not been
linked to
contaminated
beef.

1 in 1 million
people are
diagnosed
with CJD per
year (usually
older adults).

CAUSES:
abnormal versions of a protein called a
prion.

TRANSMISSION
Risk of CJD is low.
Cannot be transmitted through
coughing, sneezing, touching or sexual
contact.
CJD DEVELOPS:
• Spontaneously (majority of cases)
• Genetic mutation (family history)
• Contamination. (very low number of
exposures to infected human tissue
during a medical procedure)
ASSOCIATED SYMPTOMS:
personality
changes, anxiety, depression, memory
loss, impaired thinking, blurred
vision, insomnia
difficulty swallowing, motor issues.
Dementia
Multifactorial

AD and
another
type of
dementia
can exist at
the same
time

MD: nearly
half of the
cases
where AD
is present
Deposition
of Lewy
bodies in
both,
cortical and
subcortical

Has features
of both PD
and AD

Affects 1%
of those age
65, 5% over
age 85

Usually
progresses
more rapidly
than DAT
(average = 6
years)
PD is a
progressi
ve
disorder
of the
CNS
Results
from a
deficiency
in the
neurotran
smitter
DOPAMIN
E
Affects
more than
1.5 million
people in
the US

20-40%
have
more
severe
symptom
s/
dementia

50%+ of
people
with PD
have MCI.
Sometimes
referred to
as
WernickeKorsakoff’s
syndrome

A dementia
syndrome
caused by
many years
of heavy
drinking
Usually the
result of a
combo:
malnutrition
+ brain
damage
directly
caused by
alcohol

Accounts
for < 5% of
all
dementias
Dementia of
the Alzheimer’s
type
Mixed
Dementias

Vascular
Dementia

Huntington’s
Disease
Dementia

Frontotemporal
Dementia

Normal
Pressure
Hydrocephalus

Lewy Body
Dementia

Parkinson’s
Disease
Dementia

Alcoholinduced
Dementia
CJD
Educational programs for
families and professionals

1-800 272-3900
The Alzheimer's Association is the leading voluntary health
organization in Alzheimer’s, care, support and research.
Its mission is to eliminate Alzheimer’s disease through the
advancement of research; to provide and enhance care
and support for all affected; and to reduce the risk of
dementia through the promotion of brain health.

•
•
•
•
•
•

24-hour Helpline

Information and referrals
Care consultation
Support groups
Online community

Safety services

www.alz.org
www.vda.virginia.gov
Virginia Easy Access is a FREE resource providing a simple method to search for specific services anywhere
in Virginia. Virginia Easy Access is a gateway to VirginiaNavigator (which lists over 21,000 programs and
services throughout the Commonwealth) and to the 2-1-1 Virginia Call Center.

easyaccess.virginia.gov
seniornavigator.org
www.sahp.vcu.edu/gerontology/
OVERVIEW OF DEMENTIA

Weitere ähnliche Inhalte

Was ist angesagt?

Dementia ppt. DR HUDA BUKHARI
Dementia ppt. DR HUDA BUKHARIDementia ppt. DR HUDA BUKHARI
Dementia ppt. DR HUDA BUKHARInajamsaqib41
 
Dementia introduction slides by swapnakishore released cc-by-nc-sa
Dementia introduction slides by swapnakishore released cc-by-nc-saDementia introduction slides by swapnakishore released cc-by-nc-sa
Dementia introduction slides by swapnakishore released cc-by-nc-saSwapna Kishore
 
Approach to a patient with dementia
Approach to a patient with dementiaApproach to a patient with dementia
Approach to a patient with dementiaRobin Garg
 
Neurocognitive Disorders [2020]
Neurocognitive Disorders [2020]Neurocognitive Disorders [2020]
Neurocognitive Disorders [2020]Zahiruddin Othman
 
Neurocognitive disorders
Neurocognitive disordersNeurocognitive disorders
Neurocognitive disordersFemiOpadotun
 
Different Types of Dementia
Different Types of DementiaDifferent Types of Dementia
Different Types of DementiaMarketingTeamBiz
 
Prognosis of schizophrenia
Prognosis of schizophreniaPrognosis of schizophrenia
Prognosis of schizophreniaKarrar Husain
 
Neuropsychiatric aspects of Cerebrovascular Disorders
Neuropsychiatric aspects of Cerebrovascular DisordersNeuropsychiatric aspects of Cerebrovascular Disorders
Neuropsychiatric aspects of Cerebrovascular DisordersDr. Subhendu Sekhar Dhar
 
Neuro cognition in Schizophrenia
Neuro cognition in SchizophreniaNeuro cognition in Schizophrenia
Neuro cognition in SchizophreniaParth Goyal
 
Guidelines for Management of Dementia
Guidelines for Management of DementiaGuidelines for Management of Dementia
Guidelines for Management of DementiaRavi Soni
 
Dementia
DementiaDementia
DementiaL RAMU
 
Psychiatric manifestations of Parkinson's Disease
Psychiatric manifestations of Parkinson's DiseasePsychiatric manifestations of Parkinson's Disease
Psychiatric manifestations of Parkinson's DiseaseSoumen Karmakar
 
Neurocognitive disorders (1)
Neurocognitive disorders (1)Neurocognitive disorders (1)
Neurocognitive disorders (1)Lisa Rosema
 

Was ist angesagt? (20)

Dementia
DementiaDementia
Dementia
 
Dementia ppt. DR HUDA BUKHARI
Dementia ppt. DR HUDA BUKHARIDementia ppt. DR HUDA BUKHARI
Dementia ppt. DR HUDA BUKHARI
 
Dementia introduction slides by swapnakishore released cc-by-nc-sa
Dementia introduction slides by swapnakishore released cc-by-nc-saDementia introduction slides by swapnakishore released cc-by-nc-sa
Dementia introduction slides by swapnakishore released cc-by-nc-sa
 
Approach to a patient with dementia
Approach to a patient with dementiaApproach to a patient with dementia
Approach to a patient with dementia
 
Treatment of dementia
Treatment of dementiaTreatment of dementia
Treatment of dementia
 
Neurocognitive Disorders [2020]
Neurocognitive Disorders [2020]Neurocognitive Disorders [2020]
Neurocognitive Disorders [2020]
 
Neurocognitive disorders
Neurocognitive disordersNeurocognitive disorders
Neurocognitive disorders
 
Dementia Power. Point
Dementia Power. PointDementia Power. Point
Dementia Power. Point
 
Dementia
DementiaDementia
Dementia
 
Different Types of Dementia
Different Types of DementiaDifferent Types of Dementia
Different Types of Dementia
 
Prognosis of schizophrenia
Prognosis of schizophreniaPrognosis of schizophrenia
Prognosis of schizophrenia
 
Neuropsychiatric aspects of Cerebrovascular Disorders
Neuropsychiatric aspects of Cerebrovascular DisordersNeuropsychiatric aspects of Cerebrovascular Disorders
Neuropsychiatric aspects of Cerebrovascular Disorders
 
Neuro cognition in Schizophrenia
Neuro cognition in SchizophreniaNeuro cognition in Schizophrenia
Neuro cognition in Schizophrenia
 
Chapter 7 (revised)
Chapter 7 (revised)Chapter 7 (revised)
Chapter 7 (revised)
 
Guidelines for Management of Dementia
Guidelines for Management of DementiaGuidelines for Management of Dementia
Guidelines for Management of Dementia
 
Dementia
DementiaDementia
Dementia
 
Psychiatric manifestations of Parkinson's Disease
Psychiatric manifestations of Parkinson's DiseasePsychiatric manifestations of Parkinson's Disease
Psychiatric manifestations of Parkinson's Disease
 
Neurocognitive disorders (1)
Neurocognitive disorders (1)Neurocognitive disorders (1)
Neurocognitive disorders (1)
 
Neuro cognitive disorders
Neuro cognitive disordersNeuro cognitive disorders
Neuro cognitive disorders
 
Dementia
DementiaDementia
Dementia
 

Andere mochten auch

Dementia powerpoint
Dementia powerpoint Dementia powerpoint
Dementia powerpoint Milen Ramos
 
Alzheimer’s Disease
Alzheimer’s DiseaseAlzheimer’s Disease
Alzheimer’s Diseasehulyadiels
 
Organic Mental Disorders
Organic Mental DisordersOrganic Mental Disorders
Organic Mental Disordersdonthuraj
 
Delirium, Dementia, and Amnestic Disorders
Delirium, Dementia, and Amnestic DisordersDelirium, Dementia, and Amnestic Disorders
Delirium, Dementia, and Amnestic Disordersguestd889da58
 
Dementia Slides
Dementia SlidesDementia Slides
Dementia SlidesRandi852
 
Analytical psychology Theories of Personality Carl Jung
Analytical psychology Theories of Personality Carl JungAnalytical psychology Theories of Personality Carl Jung
Analytical psychology Theories of Personality Carl JungGrace Bran
 
Freud and neo freudians
Freud and neo freudiansFreud and neo freudians
Freud and neo freudiansasma1990
 
Neo freudians, Jung and Adler - a Seminar
Neo freudians, Jung and Adler - a Seminar Neo freudians, Jung and Adler - a Seminar
Neo freudians, Jung and Adler - a Seminar Ashutosh Ratnam
 
Dementia powerpoint
Dementia powerpointDementia powerpoint
Dementia powerpointBgross01
 

Andere mochten auch (16)

Dementia
DementiaDementia
Dementia
 
Dementia PRESENTATION
Dementia PRESENTATIONDementia PRESENTATION
Dementia PRESENTATION
 
Dementia powerpoint
Dementia powerpoint Dementia powerpoint
Dementia powerpoint
 
Alzheimer’s Disease
Alzheimer’s DiseaseAlzheimer’s Disease
Alzheimer’s Disease
 
Alzheimer
AlzheimerAlzheimer
Alzheimer
 
Dementia
DementiaDementia
Dementia
 
Organic Mental Disorders
Organic Mental DisordersOrganic Mental Disorders
Organic Mental Disorders
 
Amnestic diorder wani
Amnestic diorder  waniAmnestic diorder  wani
Amnestic diorder wani
 
Organic Mental Disorders
Organic Mental DisordersOrganic Mental Disorders
Organic Mental Disorders
 
Delirium, Dementia, and Amnestic Disorders
Delirium, Dementia, and Amnestic DisordersDelirium, Dementia, and Amnestic Disorders
Delirium, Dementia, and Amnestic Disorders
 
Dementia Slides
Dementia SlidesDementia Slides
Dementia Slides
 
Analytical psychology Theories of Personality Carl Jung
Analytical psychology Theories of Personality Carl JungAnalytical psychology Theories of Personality Carl Jung
Analytical psychology Theories of Personality Carl Jung
 
Freud and neo freudians
Freud and neo freudiansFreud and neo freudians
Freud and neo freudians
 
Neo freudians, Jung and Adler - a Seminar
Neo freudians, Jung and Adler - a Seminar Neo freudians, Jung and Adler - a Seminar
Neo freudians, Jung and Adler - a Seminar
 
Neo freudians
Neo freudiansNeo freudians
Neo freudians
 
Dementia powerpoint
Dementia powerpointDementia powerpoint
Dementia powerpoint
 

Ähnlich wie OVERVIEW OF DEMENTIA

Alzheimers 101for families
Alzheimers 101for familiesAlzheimers 101for families
Alzheimers 101for familiesalz2011
 
Neurological disorder
Neurological disorderNeurological disorder
Neurological disorderUE
 
Alzheimer's disease.pptx
Alzheimer's disease.pptxAlzheimer's disease.pptx
Alzheimer's disease.pptxNiru Magar
 
Section 6 caring for persons with confusion and dementia-1
Section 6   caring for persons with confusion and dementia-1Section 6   caring for persons with confusion and dementia-1
Section 6 caring for persons with confusion and dementia-1baxtermom
 
Dementia of alzheimer's2
Dementia of alzheimer's2Dementia of alzheimer's2
Dementia of alzheimer's2casperf4
 
ALZHEIMER’S DISEASE: IS YOUR POOR MEMORY A WARNING BELL?
ALZHEIMER’S DISEASE: IS YOUR POOR MEMORY A WARNING BELL?ALZHEIMER’S DISEASE: IS YOUR POOR MEMORY A WARNING BELL?
ALZHEIMER’S DISEASE: IS YOUR POOR MEMORY A WARNING BELL?Meds Engage
 
Alzheimer dementia disease
Alzheimer  dementia diseaseAlzheimer  dementia disease
Alzheimer dementia diseaseMOUNIR HATHROUBI
 
Alzheimer’s disease
Alzheimer’s diseaseAlzheimer’s disease
Alzheimer’s diseaseAkhil Joseph
 
Alzheimer's Disease [A Complete Picture]
Alzheimer's Disease [A Complete Picture]Alzheimer's Disease [A Complete Picture]
Alzheimer's Disease [A Complete Picture]Safoora Qureshi
 
Alzheimers ACC
Alzheimers ACCAlzheimers ACC
Alzheimers ACCAmyCriger
 
Vascular Dementia and Mixed Dementia
Vascular Dementia and Mixed DementiaVascular Dementia and Mixed Dementia
Vascular Dementia and Mixed Dementiawef
 
Alzheimer's Disease Presentation
Alzheimer's Disease PresentationAlzheimer's Disease Presentation
Alzheimer's Disease Presentationjdeguzman3
 
6.2 Human Genetic Disorders 2019
6.2 Human Genetic Disorders 20196.2 Human Genetic Disorders 2019
6.2 Human Genetic Disorders 2019alexsong2018
 
Alzheimer's Dementia vs. Occupational Therapy
Alzheimer's Dementia vs. Occupational TherapyAlzheimer's Dementia vs. Occupational Therapy
Alzheimer's Dementia vs. Occupational TherapyChevahlyan Dozier, COTA/L
 

Ähnlich wie OVERVIEW OF DEMENTIA (20)

Alzheimers 101for families
Alzheimers 101for familiesAlzheimers 101for families
Alzheimers 101for families
 
Neurological disorder
Neurological disorderNeurological disorder
Neurological disorder
 
Dementia
DementiaDementia
Dementia
 
Alzheimer's disease.pptx
Alzheimer's disease.pptxAlzheimer's disease.pptx
Alzheimer's disease.pptx
 
Alzheimer.ppt
Alzheimer.pptAlzheimer.ppt
Alzheimer.ppt
 
Dementia.pptx
Dementia.pptxDementia.pptx
Dementia.pptx
 
Section 6 caring for persons with confusion and dementia-1
Section 6   caring for persons with confusion and dementia-1Section 6   caring for persons with confusion and dementia-1
Section 6 caring for persons with confusion and dementia-1
 
Dementia of alzheimer's2
Dementia of alzheimer's2Dementia of alzheimer's2
Dementia of alzheimer's2
 
ALZHEIMER’S DISEASE: IS YOUR POOR MEMORY A WARNING BELL?
ALZHEIMER’S DISEASE: IS YOUR POOR MEMORY A WARNING BELL?ALZHEIMER’S DISEASE: IS YOUR POOR MEMORY A WARNING BELL?
ALZHEIMER’S DISEASE: IS YOUR POOR MEMORY A WARNING BELL?
 
Alzheimer dementia disease
Alzheimer  dementia diseaseAlzheimer  dementia disease
Alzheimer dementia disease
 
Alzheimer’s disease
Alzheimer’s diseaseAlzheimer’s disease
Alzheimer’s disease
 
Alzheimer's Disease [A Complete Picture]
Alzheimer's Disease [A Complete Picture]Alzheimer's Disease [A Complete Picture]
Alzheimer's Disease [A Complete Picture]
 
Alzheimers ACC
Alzheimers ACCAlzheimers ACC
Alzheimers ACC
 
Alzheimer's Disease
Alzheimer's DiseaseAlzheimer's Disease
Alzheimer's Disease
 
Vascular Dementia and Mixed Dementia
Vascular Dementia and Mixed DementiaVascular Dementia and Mixed Dementia
Vascular Dementia and Mixed Dementia
 
alzheimer
alzheimeralzheimer
alzheimer
 
Alzheimer's Disease Presentation
Alzheimer's Disease PresentationAlzheimer's Disease Presentation
Alzheimer's Disease Presentation
 
6.2 Human Genetic Disorders 2019
6.2 Human Genetic Disorders 20196.2 Human Genetic Disorders 2019
6.2 Human Genetic Disorders 2019
 
Dementia
DementiaDementia
Dementia
 
Alzheimer's Dementia vs. Occupational Therapy
Alzheimer's Dementia vs. Occupational TherapyAlzheimer's Dementia vs. Occupational Therapy
Alzheimer's Dementia vs. Occupational Therapy
 

Mehr von wef

Robin Murray commentary during the SRF webinar "Is Schizophrenia Dead Yet?"
Robin Murray commentary during the SRF webinar "Is Schizophrenia Dead Yet?"Robin Murray commentary during the SRF webinar "Is Schizophrenia Dead Yet?"
Robin Murray commentary during the SRF webinar "Is Schizophrenia Dead Yet?"wef
 
Eske Derks commentary - SRF webinar "Is Schizophrenia Dead Yet?"
Eske Derks commentary - SRF webinar "Is Schizophrenia Dead Yet?"Eske Derks commentary - SRF webinar "Is Schizophrenia Dead Yet?"
Eske Derks commentary - SRF webinar "Is Schizophrenia Dead Yet?"wef
 
Jim van Os presentation during SRF live webinar "Is Schizophrenia Dead Yet?"
Jim van Os presentation during SRF live webinar "Is Schizophrenia Dead Yet?"Jim van Os presentation during SRF live webinar "Is Schizophrenia Dead Yet?"
Jim van Os presentation during SRF live webinar "Is Schizophrenia Dead Yet?"wef
 
Rene Kahn commentary during SRF Live Webinar: "Is Schizophrenia Dead Yet?
Rene Kahn commentary during SRF Live Webinar: "Is Schizophrenia Dead Yet?Rene Kahn commentary during SRF Live Webinar: "Is Schizophrenia Dead Yet?
Rene Kahn commentary during SRF Live Webinar: "Is Schizophrenia Dead Yet?wef
 
Mark Daly - Finding risk genes in psychiatric disorders
Mark Daly - Finding risk genes in psychiatric disordersMark Daly - Finding risk genes in psychiatric disorders
Mark Daly - Finding risk genes in psychiatric disorderswef
 
NIMH i PSC Assays for the Drug Pipeline - Panchision
NIMH i PSC Assays for the Drug Pipeline -  PanchisionNIMH i PSC Assays for the Drug Pipeline -  Panchision
NIMH i PSC Assays for the Drug Pipeline - Panchisionwef
 
Schizophrenia Research Forum Live Webinar - June 28, 2017 - Rusty Gage
Schizophrenia Research Forum Live Webinar - June 28, 2017 - Rusty Gage Schizophrenia Research Forum Live Webinar - June 28, 2017 - Rusty Gage
Schizophrenia Research Forum Live Webinar - June 28, 2017 - Rusty Gage wef
 
SCHIZOPHRENIA RESEARCH FORUM - LIVE WEBINAR June 2017 Kristen Brennand
SCHIZOPHRENIA RESEARCH FORUM - LIVE WEBINAR June 2017   Kristen BrennandSCHIZOPHRENIA RESEARCH FORUM - LIVE WEBINAR June 2017   Kristen Brennand
SCHIZOPHRENIA RESEARCH FORUM - LIVE WEBINAR June 2017 Kristen Brennandwef
 
STRATEGIES FOR COMMUNICATION AND SENSITIVITY FOR PERSONS EXPERIENCING DEMENTI...
STRATEGIES FOR COMMUNICATION AND SENSITIVITY FOR PERSONS EXPERIENCING DEMENTI...STRATEGIES FOR COMMUNICATION AND SENSITIVITY FOR PERSONS EXPERIENCING DEMENTI...
STRATEGIES FOR COMMUNICATION AND SENSITIVITY FOR PERSONS EXPERIENCING DEMENTI...wef
 
Translating from Animal Models to Human Schizophrenia - Insights into Pathoph...
Translating from Animal Models to Human Schizophrenia - Insights into Pathoph...Translating from Animal Models to Human Schizophrenia - Insights into Pathoph...
Translating from Animal Models to Human Schizophrenia - Insights into Pathoph...wef
 
Dopamine: Stress, Genes and the Prodrome
Dopamine: Stress, Genes and the ProdromeDopamine: Stress, Genes and the Prodrome
Dopamine: Stress, Genes and the Prodromewef
 
Topography and functional significance of the dopaminesgic dysfunction in sch...
Topography and functional significance of the dopaminesgic dysfunction in sch...Topography and functional significance of the dopaminesgic dysfunction in sch...
Topography and functional significance of the dopaminesgic dysfunction in sch...wef
 
SRF Webinar - What It Will Take to Make Coordinated Specialty Care Available ...
SRF Webinar - What It Will Take to Make Coordinated Specialty Care Available ...SRF Webinar - What It Will Take to Make Coordinated Specialty Care Available ...
SRF Webinar - What It Will Take to Make Coordinated Specialty Care Available ...wef
 
SRF Webinar: Beyond DUP - Addressing Disengagement in Community-based Early I...
SRF Webinar: Beyond DUP - Addressing Disengagement in Community-based Early I...SRF Webinar: Beyond DUP - Addressing Disengagement in Community-based Early I...
SRF Webinar: Beyond DUP - Addressing Disengagement in Community-based Early I...wef
 
Alzheimer's and memory loss 101
Alzheimer's and memory loss 101Alzheimer's and memory loss 101
Alzheimer's and memory loss 101wef
 
Christoph Correll
Christoph CorrellChristoph Correll
Christoph Correllwef
 
Oliver Howes - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis...
Oliver Howes - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis...Oliver Howes - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis...
Oliver Howes - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis...wef
 
John Kane - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis an...
John Kane - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis an...John Kane - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis an...
John Kane - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis an...wef
 
HEAR approach to behavior management Live webinar Feb 1 2017
HEAR approach to behavior management   Live webinar Feb 1 2017HEAR approach to behavior management   Live webinar Feb 1 2017
HEAR approach to behavior management Live webinar Feb 1 2017wef
 
LBDA Webinar Bradley Boeve
LBDA Webinar Bradley BoeveLBDA Webinar Bradley Boeve
LBDA Webinar Bradley Boevewef
 

Mehr von wef (20)

Robin Murray commentary during the SRF webinar "Is Schizophrenia Dead Yet?"
Robin Murray commentary during the SRF webinar "Is Schizophrenia Dead Yet?"Robin Murray commentary during the SRF webinar "Is Schizophrenia Dead Yet?"
Robin Murray commentary during the SRF webinar "Is Schizophrenia Dead Yet?"
 
Eske Derks commentary - SRF webinar "Is Schizophrenia Dead Yet?"
Eske Derks commentary - SRF webinar "Is Schizophrenia Dead Yet?"Eske Derks commentary - SRF webinar "Is Schizophrenia Dead Yet?"
Eske Derks commentary - SRF webinar "Is Schizophrenia Dead Yet?"
 
Jim van Os presentation during SRF live webinar "Is Schizophrenia Dead Yet?"
Jim van Os presentation during SRF live webinar "Is Schizophrenia Dead Yet?"Jim van Os presentation during SRF live webinar "Is Schizophrenia Dead Yet?"
Jim van Os presentation during SRF live webinar "Is Schizophrenia Dead Yet?"
 
Rene Kahn commentary during SRF Live Webinar: "Is Schizophrenia Dead Yet?
Rene Kahn commentary during SRF Live Webinar: "Is Schizophrenia Dead Yet?Rene Kahn commentary during SRF Live Webinar: "Is Schizophrenia Dead Yet?
Rene Kahn commentary during SRF Live Webinar: "Is Schizophrenia Dead Yet?
 
Mark Daly - Finding risk genes in psychiatric disorders
Mark Daly - Finding risk genes in psychiatric disordersMark Daly - Finding risk genes in psychiatric disorders
Mark Daly - Finding risk genes in psychiatric disorders
 
NIMH i PSC Assays for the Drug Pipeline - Panchision
NIMH i PSC Assays for the Drug Pipeline -  PanchisionNIMH i PSC Assays for the Drug Pipeline -  Panchision
NIMH i PSC Assays for the Drug Pipeline - Panchision
 
Schizophrenia Research Forum Live Webinar - June 28, 2017 - Rusty Gage
Schizophrenia Research Forum Live Webinar - June 28, 2017 - Rusty Gage Schizophrenia Research Forum Live Webinar - June 28, 2017 - Rusty Gage
Schizophrenia Research Forum Live Webinar - June 28, 2017 - Rusty Gage
 
SCHIZOPHRENIA RESEARCH FORUM - LIVE WEBINAR June 2017 Kristen Brennand
SCHIZOPHRENIA RESEARCH FORUM - LIVE WEBINAR June 2017   Kristen BrennandSCHIZOPHRENIA RESEARCH FORUM - LIVE WEBINAR June 2017   Kristen Brennand
SCHIZOPHRENIA RESEARCH FORUM - LIVE WEBINAR June 2017 Kristen Brennand
 
STRATEGIES FOR COMMUNICATION AND SENSITIVITY FOR PERSONS EXPERIENCING DEMENTI...
STRATEGIES FOR COMMUNICATION AND SENSITIVITY FOR PERSONS EXPERIENCING DEMENTI...STRATEGIES FOR COMMUNICATION AND SENSITIVITY FOR PERSONS EXPERIENCING DEMENTI...
STRATEGIES FOR COMMUNICATION AND SENSITIVITY FOR PERSONS EXPERIENCING DEMENTI...
 
Translating from Animal Models to Human Schizophrenia - Insights into Pathoph...
Translating from Animal Models to Human Schizophrenia - Insights into Pathoph...Translating from Animal Models to Human Schizophrenia - Insights into Pathoph...
Translating from Animal Models to Human Schizophrenia - Insights into Pathoph...
 
Dopamine: Stress, Genes and the Prodrome
Dopamine: Stress, Genes and the ProdromeDopamine: Stress, Genes and the Prodrome
Dopamine: Stress, Genes and the Prodrome
 
Topography and functional significance of the dopaminesgic dysfunction in sch...
Topography and functional significance of the dopaminesgic dysfunction in sch...Topography and functional significance of the dopaminesgic dysfunction in sch...
Topography and functional significance of the dopaminesgic dysfunction in sch...
 
SRF Webinar - What It Will Take to Make Coordinated Specialty Care Available ...
SRF Webinar - What It Will Take to Make Coordinated Specialty Care Available ...SRF Webinar - What It Will Take to Make Coordinated Specialty Care Available ...
SRF Webinar - What It Will Take to Make Coordinated Specialty Care Available ...
 
SRF Webinar: Beyond DUP - Addressing Disengagement in Community-based Early I...
SRF Webinar: Beyond DUP - Addressing Disengagement in Community-based Early I...SRF Webinar: Beyond DUP - Addressing Disengagement in Community-based Early I...
SRF Webinar: Beyond DUP - Addressing Disengagement in Community-based Early I...
 
Alzheimer's and memory loss 101
Alzheimer's and memory loss 101Alzheimer's and memory loss 101
Alzheimer's and memory loss 101
 
Christoph Correll
Christoph CorrellChristoph Correll
Christoph Correll
 
Oliver Howes - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis...
Oliver Howes - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis...Oliver Howes - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis...
Oliver Howes - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis...
 
John Kane - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis an...
John Kane - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis an...John Kane - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis an...
John Kane - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis an...
 
HEAR approach to behavior management Live webinar Feb 1 2017
HEAR approach to behavior management   Live webinar Feb 1 2017HEAR approach to behavior management   Live webinar Feb 1 2017
HEAR approach to behavior management Live webinar Feb 1 2017
 
LBDA Webinar Bradley Boeve
LBDA Webinar Bradley BoeveLBDA Webinar Bradley Boeve
LBDA Webinar Bradley Boeve
 

Kürzlich hochgeladen

Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Celine George
 
How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17Celine George
 
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...Postal Advocate Inc.
 
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)lakshayb543
 
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfLike-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfMr Bounab Samir
 
Karra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxKarra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxAshokKarra1
 
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxBarangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxCarlos105
 
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxMULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxAnupkumar Sharma
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSJoshuaGantuangco2
 
Judging the Relevance and worth of ideas part 2.pptx
Judging the Relevance  and worth of ideas part 2.pptxJudging the Relevance  and worth of ideas part 2.pptx
Judging the Relevance and worth of ideas part 2.pptxSherlyMaeNeri
 
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfGrade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfJemuel Francisco
 
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...JhezDiaz1
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designMIPLM
 
Science 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptxScience 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptxMaryGraceBautista27
 
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...Nguyen Thanh Tu Collection
 
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Celine George
 
What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPCeline George
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxHumphrey A Beña
 
Choosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for ParentsChoosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for Parentsnavabharathschool99
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptxmary850239
 

Kürzlich hochgeladen (20)

Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17
 
How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17
 
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
 
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
 
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfLike-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
 
Karra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxKarra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptx
 
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxBarangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
 
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxMULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
 
Judging the Relevance and worth of ideas part 2.pptx
Judging the Relevance  and worth of ideas part 2.pptxJudging the Relevance  and worth of ideas part 2.pptx
Judging the Relevance and worth of ideas part 2.pptx
 
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfGrade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
 
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-design
 
Science 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptxScience 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptx
 
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
 
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
 
What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERP
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
 
Choosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for ParentsChoosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for Parents
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx
 

OVERVIEW OF DEMENTIA

  • 1. Recommended pre-requisite presentation for “The Other Dementias: Virtual Training and Active Learning on Non-Alzheimer’s Dementias” three-part series, which is made possible through a grant funded from
  • 2. TYPICAL CHANGES • Making a bad decision once in a while • Missing an occasional monthly payment • Forgetting which day it is and remembering later • Sometimes forgetting which word to use • Losing things from time to time A-TYPICAL CHANGES • Consistent poor judgment and decision making • Loss of an ability to manage money • Inability to keep track of the date or the season • Difficulty having a conversation • Misplacing things and loss of the ability to retrace steps to find them
  • 3. There are many causes of dementia symptoms. Is NOT a specific disease. Alzheimer's disease is the most common cause of a progressive dementia. Is a GROUP OF SYMPTOMS affecting intellectual and social abilities severely enough to interfere with daily functioning. Memory loss generally occurs in dementia, but memory loss alone does not imply you have dementia.
  • 5. • Depression/delirium • Medication sideeffects • Excess alcohol use • Thyroid problems • Poor diet • Vitamin deficiencies • Certain infections Reversible DEMENTIAS • • • • Alzheimer’s disease Parkinson’s Lewy-body dementia Etc. Irreversible
  • 6. 2013 Alzheimer’s Disease Facts and Figures, Alzheimer’s Association
  • 7. Alzheimer’s disease is more prevalent among African-Americans than among whites Estimates range from 14% to almost 100% higher; There is a greater familial risk of Alzheimer’s in African-Americans The cumulative risk of dementia among firstdegree relatives of AfricanAmericans who have Alzheimer’s disease is 43.7% Genetic and environmental factors may work differently to cause Alzheimer’s disease in African-Americans Data from a large-scale longitudinal study indicate that persons with a history of either high blood pressure or high cholesterol levels are twice as likely to get Alzheimer’s disease. Those with both risk factors are four times as likely to become demented. 65% of African-American Medicare beneficiaries have hypertension, compared to 51% of white beneficiaries. They are also at higher risk of stroke. (Data from the Current Medicare Beneficiary Survey) African-Americans have a 60% higher risk of type 2 diabetes — a condition that contributes directly to vascular disease. African-Americans have a higher rate of vascular dementia than white Americans. http://www.alz.org/national/documents/report_africanamericanssilentepidem
  • 8. Brain disorder, most common form of dementia Affects 5% of people at age 65 Affects 50% of people age 85+ ASSOCIATED RISK FACTORS: • • • • • • • • • • TREATMENT: • • Late-onset (65+) is most common, s lowestprogressin g Average course of DAT: 6-20 years Age Family history Down syndrome Incidence higher in women Alcohol use Atherosclerosis Blood pressure Cholesterol Depression Diabetes (type 2) • • No treatment available to slow or stop the deterioration of brain cells in Alzheimer's disease. US FDA has approved five drugs that temporarily slow worsening of symptoms for about 6 - 12 months. Effective for only about ½ of the individuals who take them. Inconclusive research: Vitamin E Anti-inflammatory drugs Estrogen Vaccine Diet INCIDENCE: AD more prevalent among African-Americans and Hispanics
  • 10. Memory loss that disrupts daily functioning Challenges in planning or solving problems Changes in mood and personality Withdrawal from work or social activities Difficulty completing familiar tasks at home, at work or at leisure Decreased or poor judgment Confusion with time or place Trouble understanding visual images and spatial relationships Misplacing things and losing the ability to retrace steps New problems with words in speaking or writing
  • 11. VaD can be cortical and subcortical 2nd most common dementia after Alzheimer's disease Result of a damage to the brain caused by problems with the arteries serving the brain or heart. Approx. 2530% of all dementias are VaD Prevalence of VaD ranges from 1 to 4 percent in people over the age of 65. CAUSES: • Untreated high blood pressure • Diabetes • High cholesterol • Heart disease ASSOCIATED SYMPTOMS: • Confusion and agitation; depression • Unsteady gait • Problems with memory • Urinary frequency, urgency, incontinence • Night wandering • Decline in ability to organize thoughts/actions, difficulty planning • Poor attention/concentration TREATMENT: Damage caused by infarcts cannot be reversed. Future cerebrovascular incidents can be controlled (control of cardiovascular risk factors)
  • 12. Pick's disease affects parts of the brain that contain fibrous tangles made up of an abnormal protein called tau protein Group of diseases characterized by the degeneration of nerve cells in the F-T areas of the brain Begins earlier and progresses faster than AD Occurs at ages younger than AD, i.e., 40-70. One form of this condition is Pick's disease. (Fronto-temporal areas of the brain are generally associated with personality, behavior and language). In these dementias, portions of these lobes atrophy. CAUSES: • Unknown • Possible genetic mutations. ASSOCIATED SYMPTOMS: • socially inappropriate behaviors • loss of mental flexibility • decline in personal hygiene • language problems, and • movement disorders • difficulty with concentration and thinking.
  • 13. CJD is a degenerative brain disorder that leads to dementia and, ultimately, death. (rapid progression) Variant CJD is linked primarily to eating beef infected with bovine spongiform encephalopathy (mad cow disease. The "classic" CreutzfeldtJakob disease has not been linked to contaminated beef. 1 in 1 million people are diagnosed with CJD per year (usually older adults). CAUSES: abnormal versions of a protein called a prion. TRANSMISSION Risk of CJD is low. Cannot be transmitted through coughing, sneezing, touching or sexual contact. CJD DEVELOPS: • Spontaneously (majority of cases) • Genetic mutation (family history) • Contamination. (very low number of exposures to infected human tissue during a medical procedure) ASSOCIATED SYMPTOMS: personality changes, anxiety, depression, memory loss, impaired thinking, blurred vision, insomnia difficulty swallowing, motor issues.
  • 14. Dementia Multifactorial AD and another type of dementia can exist at the same time MD: nearly half of the cases where AD is present
  • 15. Deposition of Lewy bodies in both, cortical and subcortical Has features of both PD and AD Affects 1% of those age 65, 5% over age 85 Usually progresses more rapidly than DAT (average = 6 years)
  • 16. PD is a progressi ve disorder of the CNS Results from a deficiency in the neurotran smitter DOPAMIN E Affects more than 1.5 million people in the US 20-40% have more severe symptom s/ dementia 50%+ of people with PD have MCI.
  • 17. Sometimes referred to as WernickeKorsakoff’s syndrome A dementia syndrome caused by many years of heavy drinking Usually the result of a combo: malnutrition + brain damage directly caused by alcohol Accounts for < 5% of all dementias
  • 19. Educational programs for families and professionals 1-800 272-3900 The Alzheimer's Association is the leading voluntary health organization in Alzheimer’s, care, support and research. Its mission is to eliminate Alzheimer’s disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health. • • • • • • 24-hour Helpline Information and referrals Care consultation Support groups Online community Safety services www.alz.org
  • 21. Virginia Easy Access is a FREE resource providing a simple method to search for specific services anywhere in Virginia. Virginia Easy Access is a gateway to VirginiaNavigator (which lists over 21,000 programs and services throughout the Commonwealth) and to the 2-1-1 Virginia Call Center. easyaccess.virginia.gov

Hinweis der Redaktion

  1. Hello. Today we are going to discuss Alzheimer’s disease briefly, but focus on the “other” dementias. This is a brief overview rather than an in-depth study.
  2. Many people worry about becoming more forgetful as they grow older. Our brains change as we age, just like the rest of our bodies. We all misplace our keys once in a while; we all enter a room forgetting why we went there in the first place. Does this mean we have “dementia”? Probably not. Serious memory loss, confusion, and other major changes in the way our minds work are not typical parts of aging. Many conditions can disrupt memory and mental function. If symptoms such as consistent poor judgment; inability to manage money; difficulty with keeping track of date or time; difficulty conversing; or misplacing things but unable to retrace steps are noticed – it is time to see a doctor. Symptoms that interfere with daily function should be addressed. However, keep in mind, there are many causes for symptoms, some causes can be treated. And that is why it is important to be checked out by a physician.
  3. There is often confusion with terms. So, to begin let’s take a look at Dementia. Dementia is actually an umbrella term describing a variety of diseases and conditions that develop when nerve cells in the brain (called neurons) die or no longer function normally. The death or malfunction of neurons causes changes in one’s memory, behavior and ability to think clearly.
  4. Physicians often define dementia based on the criteria given in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).(1) To meet DSM-IV criteria for dementia, the following are required: • Symptoms must include decline in memory and in at least one of the following cognitive abilities:1) Ability to speak coherently or understand spokenor written language.2) Ability to recognize or identify objects, assumingintact sensory function.3) Ability to perform motor activities, assumingintact motor abilities and sensory function andcomprehension of the required task.4) Ability to think abstractly, make sound judgmentsand plan and carry out complex tasks.• The decline in cognitive abilities must be severeenough to interfere with daily life.
  5. To establish a diagnosis of dementia, a physician must determine the cause of the dementia-like symptoms. Some conditions have symptoms that mimic dementia but that, unlike dementia, can be reversed with treatment – such as those listed here. In contrast, dementia is caused by irreversible damage to brain cells.
  6. Alzheimer’s disease, a progressive, degenerative disease of the brain, was first identified more than 100 years ago, but research into its symptoms, causes, risk factors and treatment has gained momentum only in the last 30 years. Although research has revealed a great deal about Alzheimer’s, the precise changes in the brain that trigger the development of Alzheimer’s, and the order in which they occur, largely remain unknown. The only exceptions are certain rare, inherited forms of thedisease caused by known genetic mutations.
  7. AD IS Most common type of dementia; accounts for an estimated 60 to 80 percent of cases. Difficulty remembering names and recent events is often an early clinical symptom; apathy and depression are also often early symptoms. Later symptoms include impaired judgment, disorientation, confusion, behavior changes and difficulty speaking, swallowing and walking. New criteria and guidelines for diagnosing Alzheimer’s were proposed in 2011. They recommend that Alzheimer’s disease be considered a disease that begins well before the development of symptoms.Hallmark brain abnormalities are deposits of the protein fragment beta-amyloid (plaques) and twisted strands of the protein tau (tangles) as well as evidence of nerve cell damage and death in the brain.
  8. Add notes…
  9. Previously known as multi-infarct or post-stroke dementia, vascular dementia is less common as a sole causeof dementia than is Alzheimer’s disease. Impaired judgment or ability to make plans is more likely to be the initial symptom, as opposed to the memoryloss often associated with the initial symptoms of Alzheimer’s. Vascular dementia occurs because of brain injuries such as microscopic bleeding and blood vessel blockage. The location of the brain injury determines how the individual’s thinking and physical functioning are affected. In the past, evidence of vascular dementia was used to exclude a diagnosis of Alzheimer’s disease (and vice versa). That practice is no longer considered consistent with pathologic evidence, which shows that the brain changes of both types of dementia can be present simultaneously. When any two or more types of dementiaare present at the same time, the individual is considered to have “mixed dementia.”
  10. Includes dementias such as behavioral variant FTLD, primary progressive aphasia, Pick’s disease and progressive supranuclear palsy.Typical symptoms include changes in personality and behavior and difficulty with language. Nerve cells in the front and side regions of the brain are especially affected. No distinguishing microscopic abnormality is linked to all cases. The brain changes of behavioral variant FTLD may be present at the same time as the brain changes of Alzheimer’s, but people with behavioral variant FTLD generally develop symptoms at a younger age(at about age 60) and survive for fewer years than those with Alzheimer’s.
  11. Rapidly fatal disorder that impairs memory and coordination and causes behavior changes. Results from an infectious misfolded protein (prion) that causes other proteins throughout the brain to misfold and thus malfunction. Variant Creutzfeldt-Jakob disease is believed to be caused by consumption of products from cattle affected by mad cow disease.
  12. Mixed dementia is characterized by the hallmark abnormalities of AD and aother type of dementia – most commonly, vasuclar dementia, but, also, other types – such as dementia with lewy bodies. Recent studies suggest that mixed dementia is more common than previously thought.
  13. People with DLB have some of the symptoms common in Alzheimer’s, but are more likely than people with Alzheimer’s to have initial or early symptoms such as sleep disturbances, well-formed visual hallucinations, and muscle rigidity or other parkinsonian movement features. Lewy bodies are abnormal aggregations (or clumps) of the protein alpha-synuclein. When they develop in a part of the brain called the cortex, dementia can result. Alpha-synuclein also aggregates in the brains of people with Parkinson’s disease, but the aggregates may appear in a pattern that is different from DLB.The brain changes of DLB alone can cause dementia, or they can be present at the same time as the brain changes of Alzheimer’s disease and/or vascular dementia, with each entity contributing to the development of dementia. When this happens, the individual is said to have “mixed dementia.”
  14. As Parkinson’s disease progresses, it often results in a severe dementia similar to DLB or Alzheimer’s. Problems with movement are a common symptom early in the disease. Alpha-synuclein aggregates are likely to begin in an area deep in the brain called the substantianigra. The aggregates are thought to cause degeneration of the nerve cells that produce dopamine. The incidence of Parkinson’s disease is about one-tenth that of Alzheimer’s disease.
  15. Ellen
  16. Ellen
  17. Ellen
  18. Ayn